Moya-Alvarez Violeta, Cottrell Gilles, Ouédraogo Smaila, Accrombessi Manfred, Massougbodgi Achille, Cot Michel
Réseau doctoral de l'Ecole des Hautes Etudes en Santé Publique, Rennes, France.
UMR 216 Institut de Recherche pour le Développement, Mère et enfant face aux infections tropicales (MERIT), Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Am J Trop Med Hyg. 2017 Aug;97(2):497-503. doi: 10.4269/ajtmh.16-0001. Epub 2017 Jul 19.
The World Health Organization (WHO) estimates that 40% of children in low-income countries are anemic. Therefore, iron supplements are recommended by WHO in areas with high anemia rates. However, some studies have set into question the benefits of iron supplementation in malaria-endemic regions. In Benin, a west African country with high prevalence of anemia and malaria, no iron supplements are given systematically to infants so far despite the WHO recommendations. In this context, we wanted to investigate the effect of iron levels during the first year of life on malarial risk in Benin considering complementary risk factors. We followed 400 women and their offspring between January 2010 and June 2012 in Allada (Benin). Environmental, obstetric, and numerous clinical, maternal, and infant risk factors were considered. In multilevel models, high iron levels were significantly associated with the risk of a positive blood smear (adjusted odds ratio = 2.90, < 0.001) and parasitemia (beta estimate = 0.38, < 0.001). Infants with iron levels in the lowest quartile were less likely to have a positive blood smear ( < 0.001), and the risk increased with higher iron levels. Our results appeal for additional evaluation of the effect of different doses of iron supplements on the infant health status, including malaria incidence. Thus, the health status of infants should be compared between cohorts where iron is given either for prevention or anemia treatment, to better understand the effect of iron supplements on infant health.
世界卫生组织(WHO)估计,低收入国家40%的儿童患有贫血症。因此,WHO建议在贫血率高的地区补充铁剂。然而,一些研究对疟疾流行地区补充铁剂的益处提出了质疑。在贝宁这个贫血和疟疾高发的西非国家,尽管有WHO的建议,但目前尚未对婴儿系统性地补充铁剂。在此背景下,考虑到其他相关风险因素,我们想要研究贝宁婴儿出生后第一年的铁水平对疟疾风险的影响。2010年1月至2012年6月,我们在贝宁的阿拉达跟踪研究了400名妇女及其后代。研究考虑了环境、产科以及众多临床、母亲和婴儿方面的风险因素。在多水平模型中,高铁水平与血涂片阳性风险(调整优势比=2.90,<0.001)和寄生虫血症(β估计值=0.38,<0.001)显著相关。铁水平处于最低四分位数的婴儿血涂片呈阳性的可能性较小(<0.001),且风险随着铁水平升高而增加。我们的研究结果呼吁对不同剂量铁补充剂对婴儿健康状况(包括疟疾发病率)的影响进行更多评估。因此,应该比较给予铁剂用于预防或治疗贫血的队列中婴儿的健康状况,以便更好地了解铁补充剂对婴儿健康的影响。